Torthaí cuardaigh - Andrea B. Apolo

Beachtaigh na torthaí
  1. 1
    Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer

    Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer de réir Andrea B. Apolo, Neeta Pandit‐Taskar, Michael J. Morris

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Targeted therapies in urothelial carcinoma

    Targeted therapies in urothelial carcinoma de réir Monalisa Ghosh, Sam J. Brancato, Piyush K. Agarwal, Andrea B. Apolo

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Immunotherapy: a new treatment paradigm in bladder cancer

    Immunotherapy: a new treatment paradigm in bladder cancer de réir Nicole N. Davarpanah, Akira Yuno, Jane B. Trepel, Andrea B. Apolo

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Trimodality Therapy in Bladder Cancer

    Trimodality Therapy in Bladder Cancer de réir Christopher Premo, Andrea B. Apolo, Piyush K. Agarwal, Deborah E. Citrin

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Multimodal management of muscle-invasive bladder cancer

    Multimodal management of muscle-invasive bladder cancer de réir Jong‐Chul Park, Deborah E. Citrin, Piyush K. Agarwal, Andrea B. Apolo

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss

    Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss de réir Bharath Ramaswamy, Soumen Roy, Andrea B. Apolo, Benjamin Shapiro, Didier A. Depireux

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review

    Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review de réir Bradley A. McGregor, Amir Mortazavi, Lisa M. Cordes, Cristina Salabao, Susan Vandlik, Andrea B. Apolo

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer

    Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer de réir Andrea B. Apolo, Jamie C. Riches, Heiko Schöder, Oğuz Akın, A. Trout, Matthew I. Milowsky, Dean F. Bajorin

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival

    Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival de réir Juliane Manitz, Sandra P. D’Angelo, Andrea B. Apolo, S. Peter Eggleton, Marcis Bajars, Oliver Bohnsack, James L. Gulley

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Cabozantinib for the treatment of solid tumors: a systematic review

    Cabozantinib for the treatment of solid tumors: a systematic review de réir Pablo Maroto, Camillo Porta, Jaume Capdevila, Andrea B. Apolo, Santiago Viteri, Cristina Rodríguez‐Antona, Lidia Martín, Daniel Castellano

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report

    Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report de réir Cecilia Monge, Hoyoung Maeng, Alessandra Brofferio, Andrea B. Apolo, Bharath Sathya, Andrew E. Arai, James L. Gulley, Marijo Bilušić

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib

    Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib de réir Rena C. Zuo, Andrea B. Apolo, John J. DiGiovanna, Howard L. Parnes, Corrine Keen, Swati Nanda, William L. Dahut, Edward W. Cowen

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy

    Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy de réir Andrea B. Apolo, Irina Ostrovnaya, Susan Halabi, Alexia Iasonos, George Philips, Jonathan E. Rosenberg, Jamie C. Riches, Eric J. Small, Matthew I. Milowsky, Dean F. Bajorin

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer

    Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer de réir Vid Leko, Lucas A. McDuffie, Zhili Zheng, Jared J. Gartner, Todd D. Prickett, Andrea B. Apolo, Piyush K. Agarwal, Steven A. Rosenberg, Yong‐Chen Lu

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions

    Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions de réir Nick G. Cowan, Yiyi Chen, Tracy M. Downs, Bernard H. Bochner, Andrea B. Apolo, Michael P. Porter, Jeffrey C. La Rochelle, Christopher L. Amling, Theresa M. Koppie

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90- Targeted Therapy

    Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90- Targeted Therapy de réir Soraya Alarcon, Mehdi Mollapour, M.-J. Lee, Shinji Tsutsumi, S. Lee, Y.S. Kim, Thomas L. Prince, Andrea B. Apolo, Giuseppe Giaccone, Wanping Xu, Len Neckers, Jane B. Trepel

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer

    Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer de réir Arjun Vasant Balar, Andrea B. Apolo, Irina Ostrovnaya, Svetlana Mironov, Alexia Iasonos, A. Trout, Ashley Marie Regazzi, Ilana Garcia-Grossman, David Gallagher, Matthew I. Milowsky, Dean F. Bajorin

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Advances in medical imaging for the diagnosis and management of common genitourinary cancers

    Advances in medical imaging for the diagnosis and management of common genitourinary cancers de réir Mohammadhadi Bagheri, Mark A. Ahlman, Liza Lindenberg, Barış Türkbey, Jeffrey Lin, A. Cahid Civelek, Ashkan A. Malayeri, Piyush K. Agarwal, Peter L. Choyke, Les Folio, Andrea B. Apolo

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial

    Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, rando... de réir David Cella, Robert J. Motzer, Cristina Suárez, Steven I. Blum, Flavia Ejzykowicz, Melissa Hamilton, Joel Wallace, Burçin Şimşek, Joshua Zhang, Cristina Ivanescu, Andrea B. Apolo, Toni K. Choueiri

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies

    Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies de réir Carl Noble, Sapna Gangaputra, Ian Thompson, Amy Yuan, Andrea B. Apolo, Jung‐Min Lee, George N. Papaliodis, Shilpa Kodati, Rachel Bishop, M. Teresa Magone, Lucia Sobrin, H. Nida Sen

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: